Reapplix
Birker├╕d
About Reapplix
Reapplix ApS, a research and development company, identifies blood-derived proteins that improve wound healing, isolates them, and reapplies them to patients with chronic wounds. The company was founded in 2008 and is based in Birkerod, Denmark.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $31.6M
- Funding stage: Early Stage Venture
- Last round: Series A (Jul 2020)
- Website: reapplix.com
- Phone: 45 45 81 19 62
Industries & Categories
Biotechnology, Medical Device, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/reapplix-37772 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.